癌症发热性中性粒细胞减少患者的门诊治疗。 - Suppr | 超能文献

Outpatient treatment of febrile neutropenic patients with cancer.

作者信息

Rubenstein E B, Rolston K V

机构信息

Department of Medical Specialties, University of Texax M.D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Eur J Cancer. 1995;31A(1):2-4. doi: 10.1016/0959-8049(94)00456-f.

DOI:10.1016/0959-8049(94)00456-f

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Outpatient treatment of febrile neutropenic patients with cancer.癌症发热性中性粒细胞减少患者的门诊治疗。

Eur J Cancer. 1995;31A(1):2-4. doi: 10.1016/0959-8049(94)00456-f.

2

Outpatient antibiotic therapy in febrile neutropenic patients undergoing high-dose chemotherapy and autologous bone marrow support.接受大剂量化疗和自体骨髓支持的发热性中性粒细胞减少患者的门诊抗生素治疗。

J Clin Oncol. 1994 Nov;12(11):2516-7. doi: 10.1200/JCO.1994.12.11.2516.

3

[Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].[以发热性中性粒细胞减少症的抗生素治疗为例探讨肿瘤门诊支持性措施的可能性与局限性]

Wien Med Wochenschr. 1998;148(18):427-32.

4

Outpatient treatment with ceftriaxone alone or in combination with teicoplanin in febrile neutropenic children and adolescents with cancer.癌症发热性中性粒细胞减少儿童和青少年单独使用头孢曲松或联合替考拉宁的门诊治疗。

J Pediatr. 1997 Mar;130(3):500-1. doi: 10.1016/s0022-3476(97)70224-5.

5

Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.头孢曲松单独或与替考拉宁联合用于门诊治疗癌症中性粒细胞减少儿童和青少年发热性疾病

Klin Padiatr. 1993 Jul-Aug;205(4):295-9. doi: 10.1055/s-2007-1025240.

6

[Antibiotics in patients with fever and neutropenia].[发热伴中性粒细胞减少患者的抗生素治疗]

Dtsch Med Wochenschr. 2013 Jun;138(23):1217-20. doi: 10.1055/s-0033-1343228. Epub 2013 May 29.

7

Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.日本不明原因发热的中性粒细胞减少症患者管理临床指南：日本发热性中性粒细胞减少症研究组的验证

Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S123-7; discussion S133-40. doi: 10.1016/j.ijantimicag.2005.08.001. Epub 2005 Oct 24.

8

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.一项针对菌血症低风险的发热性中性粒细胞减少症癌症患儿门诊管理的试点研究。

J Pediatr. 1996 Jun;128(6):847-9. doi: 10.1016/s0022-3476(96)70339-6.

9

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.1997年美国感染病学会关于不明原因发热的中性粒细胞减少患者抗菌药物使用的指南。

Clin Infect Dis. 1997 Sep;25(3):551-73. doi: 10.1086/513764.

10

Response rates to a staged antibiotic regimen in febrile neutropenic patients.

J Antimicrob Chemother. 1988 Nov;22(5):759-63. doi: 10.1093/jac/22.5.759.

引用本文的文献

1

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.口服莫西沙星或静脉注射头孢曲松用于治疗适合早期出院的癌症患者低风险中性粒细胞减少性发热。

Support Care Cancer. 2008 Sep;16(9):1017-23. doi: 10.1007/s00520-007-0383-z. Epub 2008 Jan 15.

2

Nature and outcome of febrile episodes in patients with pancreatic and hepatobiliary cancer.

Support Care Cancer. 1995 Nov;3(6):414-7. doi: 10.1007/BF00364982.